Syringe
Granted 18 Jun 2019 · no office action yet
Current assignee: HPS INVESTMENT PARTNERS, LLC · originally Vertice Pharma, LLC
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Indranil Nandi, Ketan Hippalgaonkar, Sunil Vandse · Examiner: David G Muller · AU 2914 · TC 2900
Life of the patent
2 dated eventsDescription
1 parts›FIG. 1 is a front perspective view of…
FIG. 1 is a front perspective view of a syringe showing our new design;
FIG. 2 is a front view thereof;
FIG. 3 is a rear view thereof;
FIG. 4 is a right side view thereof;
FIG. 5 is a left side view thereof;
FIG. 6 is a top view thereof;
FIG. 7 is a bottom view thereof; and,
FIG. 8 is a rear perspective view thereof.
Oblique line shading represents portions of our new design that are transparent or translucent.
Solid gray shading represents a color contrast in the sense that the portions of our new design so shaded, which may be any “color”, for example, red, blue, green, or yellow, are in color contrast with the transparent or translucent portions of our new design.
In FIGS. 1-6 and 8 , the solid gray shading varies in tone and thus includes light solid gray shading and dark solid gray shading. The light solid gray shading represents the solid gray shaded portions of our new design when viewed through the transparent or translucent portions of our new design. The dark solid dark gray shading represents the solid gray shaded portions of our new design when not viewed through the transparent or translucent portions of our new design.
Claims
1 · 1 independent · depth 1Classifications
1 codesClaim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this patent are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockChain of title
See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.
Log in to unlockTerm & fees
See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.
Log in to unlockValidity challenges
See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.
Log in to unlockCitations
See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.
Log in to unlock